Literature DB >> 22578533

Effect of letrozole on estradiol production and P450 aromatase messenger RNA expression of cultured luteinized granulosa cells from women with and without endometriosis.

Xiang Lu1, Yu Wu, Xiao-Hong Gao, Yong-Wei Wang, Li Wang, Xiao-Xi Sun.   

Abstract

OBJECTIVE: To compare the estradiol production and P450 aromatase messenger RNA (mRNA) expression of cultured luteinized granulosa cells and the effect of letrozole on these parameters between women with and without endometriosis.
DESIGN: In vitro assays.
SETTING: Reproductive medical center. PATIENT(S): Patients undergoing in vitro fertilization (IVF): 23 patients with endometriosis and 19 controls without endometriosis. INTERVENTION(S): Luteinized granulosa cells examined for estradiol levels and P450 aromatase mRNA expression in conditioned media at different letrozole concentrations of 0.0, 0.1, 1.0, and 10.0 μmol/L. MAIN OUTCOME MEASURE(S): Estradiol levels of the conditioned medium measured with an enzyme-linked immunosorbent assay (ELISA) kit and P450 aromatase mRNA expression determined by quantitative reverse transcription-polymerase chain reaction (QT RT-PCR). RESULT(S): The estradiol concentration of the conditioned media and P450 aromatase mRNA expression in the endometriosis group were statistically significantly lower than that of the control group, irrespective of letrozole concentrations. A statistically significant reduction of these two parameters was observed in both endometriosis and control groups at letrozole concentrations of 1 μmol/L and 10 μmol/L, but there were no statistically significant differences between letrozole concentrations of 1 μmol/L and 10 μmol/L. The number of high-quality embryos in the endometriosis group was statistically significantly lower than that of the control group. CONCLUSION(S): Lower estradiol production and P450 aromatase mRNA expression of cultured granulosa cells were found in women with endometriosis. Letrozole in the conditioned media further reduced these parameters.
Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22578533     DOI: 10.1016/j.fertnstert.2012.03.055

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Epigenetic alterations of CYP19A1 gene in Cumulus cells and its relevance to infertility in endometriosis.

Authors:  Elham Hosseini; Fereshteh Mehraein; Maryam Shahhoseini; Leili Karimian; Fatemeh Nikmard; Mahnaz Ashrafi; Parvaneh Afsharian; Reza Aflatoonian
Journal:  J Assist Reprod Genet       Date:  2016-05-11       Impact factor: 3.412

2.  Assessment of density gradient centrifugation (DGC) and sperm chromatin dispersion (SCD) measurements in couples with male factor infertility undergoing ICSI.

Authors:  Min Wang; Jian Sun; Li Wang; Xiaohong Gao; Xiang Lu; Zhengmu Wu; Yongwei Wang; Kai Liu; Jiewei Tao; Yu Wu
Journal:  J Assist Reprod Genet       Date:  2014-09-17       Impact factor: 3.412

3.  Local production of neurostradiol affects gonadotropin-releasing hormone (GnRH) secretion at mid-gestation in Lagostomus maximus (Rodentia, Caviomorpha).

Authors:  Santiago E Charif; Pablo I F Inserra; Alejandro R Schmidt; Noelia P Di Giorgio; Santiago A Cortasa; Candela R Gonzalez; Victoria Lux-Lantos; Julia Halperin; Alfredo Daniel Vitullo; Verónica B Dorfman
Journal:  Physiol Rep       Date:  2017-10-16

Review 4.  The impact of phthalate on reproductive function in women with endometriosis.

Authors:  Ya-Ching Chou; Chii-Ruey Tzeng
Journal:  Reprod Med Biol       Date:  2021-01-11

Review 5.  Aromatase Inhibitors for Endometriosis-Associated Infertility; Do We Have Sufficient Evidence?

Authors:  Hatem Abu Hashim
Journal:  Int J Fertil Steril       Date:  2016-09-05

Review 6.  Endometriosis: current challenges in modeling a multifactorial disease of unknown etiology.

Authors:  Helena Malvezzi; Eliana Blini Marengo; Sérgio Podgaec; Carla de Azevedo Piccinato
Journal:  J Transl Med       Date:  2020-08-12       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.